Your browser doesn't support javascript.
loading
Why not eliminate HTLV-1 while eliminating HIV-1?
Maertens, Goedele N; Purcell, Damian F J; Rosadas, Carolina; Bradshaw, Daniel; Biglione, Mirna; Taylor, Graham P; Martin, Fabiola.
  • Maertens GN; Department of Infectious Disease, Imperial College London, London W2 1PG, UK. Electronic address: g.maertens@imperial.ac.uk.
  • Purcell DFJ; Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, VIC, Australia.
  • Rosadas C; Department of Infectious Disease, Imperial College London, London W2 1PG, UK.
  • Bradshaw D; Virus Reference Department, UK Health Security Agency, London, UK; National Centre for Human Retrovirology, Imperial College Healthcare NHS Trust, London, UK.
  • Biglione M; Instituto de Investigaciones Biomedicas en Retrovirus y SIDA (INBIRS), CONICET-Universidad de Buenos Aires, Buenos Aires, Argentina.
  • Taylor GP; Department of Infectious Disease, Imperial College London, London W2 1PG, UK; National Centre for Human Retrovirology, Imperial College Healthcare NHS Trust, London, UK.
  • Martin F; Canberra Sexual Health Centre, Canberra Health Services, Canberra, ACT, Australia; School of Medicine and Psychology, Australian National University, Canberra, ACT, Australia; School of Public Health, University of Queensland, Brisbane, QLD, Australia.
Lancet ; 403(10441): 2288-2289, 2024 May 25.
Article en En | MEDLINE | ID: mdl-38796201
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Infecciones por HTLV-I / Infecciones por VIH Límite: Humans Idioma: En Año: 2024 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Infecciones por HTLV-I / Infecciones por VIH Límite: Humans Idioma: En Año: 2024 Tipo del documento: Article